Influence of Iron on the Gut Microbiota in Colorectal Cancer

Research output: Contribution to journalReview articlepeer-review

Standard

Influence of Iron on the Gut Microbiota in Colorectal Cancer. / Phipps, Oliver; Al-Hassi, Hafid O; Quraishi, Mohammed N; Kumar, Aditi; Brookes, Matthew J.

In: Nutrients, Vol. 12, No. 9, 20.08.2020.

Research output: Contribution to journalReview articlepeer-review

Harvard

APA

Vancouver

Author

Phipps, Oliver ; Al-Hassi, Hafid O ; Quraishi, Mohammed N ; Kumar, Aditi ; Brookes, Matthew J. / Influence of Iron on the Gut Microbiota in Colorectal Cancer. In: Nutrients. 2020 ; Vol. 12, No. 9.

Bibtex

@article{50d77f45f8cb4cf7b22a85cd0994b0c1,
title = "Influence of Iron on the Gut Microbiota in Colorectal Cancer",
abstract = "Perturbations of the colonic microbiota can contribute to the initiation and progression of colorectal cancer, leading to an increase in pathogenic bacteria at the expense of protective bacteria. This can contribute to disease through increasing carcinogenic metabolite/toxin production, inducing inflammation, and activating oncogenic signaling. To limit disease progression, external factors that may influence the colonic microbiota need to be considered in patients with colorectal cancer. One major factor that can influence the colonic microbiota is iron. Iron is an essential micronutrient that is required by both prokaryotes and eukaryotes for cellular function. Most pathogenic bacteria have heightened iron acquisition mechanisms and therefore tend to outcompete protective bacteria for free iron. Colorectal cancer patients often present with anemia due to iron deficiency, and thus they require iron therapy. Depending upon the route of administration, iron therapy has the potential to contribute to a procarciongenic microbiota. Orally administered iron is the common treatment for anemia in these patients but can lead to an increased gut iron concentration. This suggests the need to reassess the route of iron therapy in these patients. Currently, this has only been assessed in murine studies, with human trials being necessary to unravel the potential microbial outcomes of iron therapy.",
author = "Oliver Phipps and Al-Hassi, {Hafid O} and Quraishi, {Mohammed N} and Aditi Kumar and Brookes, {Matthew J}",
year = "2020",
month = aug,
day = "20",
doi = "10.3390/nu12092512",
language = "English",
volume = "12",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "9",

}

RIS

TY - JOUR

T1 - Influence of Iron on the Gut Microbiota in Colorectal Cancer

AU - Phipps, Oliver

AU - Al-Hassi, Hafid O

AU - Quraishi, Mohammed N

AU - Kumar, Aditi

AU - Brookes, Matthew J

PY - 2020/8/20

Y1 - 2020/8/20

N2 - Perturbations of the colonic microbiota can contribute to the initiation and progression of colorectal cancer, leading to an increase in pathogenic bacteria at the expense of protective bacteria. This can contribute to disease through increasing carcinogenic metabolite/toxin production, inducing inflammation, and activating oncogenic signaling. To limit disease progression, external factors that may influence the colonic microbiota need to be considered in patients with colorectal cancer. One major factor that can influence the colonic microbiota is iron. Iron is an essential micronutrient that is required by both prokaryotes and eukaryotes for cellular function. Most pathogenic bacteria have heightened iron acquisition mechanisms and therefore tend to outcompete protective bacteria for free iron. Colorectal cancer patients often present with anemia due to iron deficiency, and thus they require iron therapy. Depending upon the route of administration, iron therapy has the potential to contribute to a procarciongenic microbiota. Orally administered iron is the common treatment for anemia in these patients but can lead to an increased gut iron concentration. This suggests the need to reassess the route of iron therapy in these patients. Currently, this has only been assessed in murine studies, with human trials being necessary to unravel the potential microbial outcomes of iron therapy.

AB - Perturbations of the colonic microbiota can contribute to the initiation and progression of colorectal cancer, leading to an increase in pathogenic bacteria at the expense of protective bacteria. This can contribute to disease through increasing carcinogenic metabolite/toxin production, inducing inflammation, and activating oncogenic signaling. To limit disease progression, external factors that may influence the colonic microbiota need to be considered in patients with colorectal cancer. One major factor that can influence the colonic microbiota is iron. Iron is an essential micronutrient that is required by both prokaryotes and eukaryotes for cellular function. Most pathogenic bacteria have heightened iron acquisition mechanisms and therefore tend to outcompete protective bacteria for free iron. Colorectal cancer patients often present with anemia due to iron deficiency, and thus they require iron therapy. Depending upon the route of administration, iron therapy has the potential to contribute to a procarciongenic microbiota. Orally administered iron is the common treatment for anemia in these patients but can lead to an increased gut iron concentration. This suggests the need to reassess the route of iron therapy in these patients. Currently, this has only been assessed in murine studies, with human trials being necessary to unravel the potential microbial outcomes of iron therapy.

U2 - 10.3390/nu12092512

DO - 10.3390/nu12092512

M3 - Review article

C2 - 32825236

VL - 12

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 9

ER -